News

Genmab's Share Capital Boost from Employee Warrant Exercise

Genmab's Share Capital Boost from Employee Warrant Exercise

Genmab Boosts Share Capital Through Employee Warrant Exercise

Company Announcement

On November 18, 2025, Genmab A/S (NASDAQ: GMAB) announced the increase of its share capital following the exercise of employee warrants.

This increase involves a total of 32,059 new shares, issued without preemption rights for existing shareholders or others. The shares will be subscribed at various cash prices, breaking down as follows:

10,033 shares at DKK 1,025.00,
310 shares at DKK 1,147.50,
1,478 shares at DKK 1,161.00,
5,847 shares at DKK 1,334.50,
675 shares at DKK 1,362.50, and
13,716 shares at DKK 1,615.00.

The company anticipates proceeds totaling approximately DKK 43.2 million from this capital increase, which represents about 0.05% of Genmab's total share capital.

Once registered with the Danish Business Authority, the new shares will be ordinary shares, fully transferable and without any special rights. They will confer rights to dividends and other rights associated with Genmab as of subscription.

According to section 32 of the Danish Capital Markets Act, the adjusted nominal value of Genmab A/S' share capital post-increase is recorded at DKK 64,238,408, comprised of 64,238,408 shares, each with a nominal value of DKK 1, equating to an equal number of votes.

About Genmab

Genmab is a leading international biotechnology firm dedicated to advancing innovative antibody therapeutics that aim to improve patients' lives. Established in 1999 and headquartered in Copenhagen, Denmark, Genmab has over 25 years of expertise in developing advanced antibody technology platforms. The company leverages cutting-edge quantitative and data sciences, creating a diverse pipeline of therapeutic solutions.

Genmab's portfolio includes novel therapies such as bispecific T-cell engagers, adorable antibody-drug conjugates, and next-generation immune checkpoint modulators among others. By 2030, Genmab envisions a transformative approach for individuals facing cancer and serious diseases through its groundbreaking antibody medicines.

The company operates globally, extending its innovative reach across North America, Europe, and the Asia Pacific region. For additional insights, their official site operates as a comprehensive resource.

Contact Information

For further inquiries, please contact:

Marisol Peron, Senior Vice President, Global Communications & Corporate Affairs
T: +1 609 524 0065; E: mmp@genmab.com

Andrew Carlsen, Vice President, Head of Investor Relations
T: +45 3377 9558; E: acn@genmab.com

Frequently Asked Questions

What prompted the increase in Genmab's share capital?

The capital increase resulted from the exercise of employee warrants.

How many new shares are being issued by Genmab?

A total of 32,059 new shares are being issued.

What will the proceeds from the share capital increase be used for?

The proceeds, approximately DKK 43.2 million, will support Genmab's ongoing research and development initiatives.

When will the new shares be listed?

The new shares are expected to be listed on Nasdaq Copenhagen following their registration with the Danish Business Authority.

What is Genmab's vision for the future?

Genmab aims to transform the lives of patients through innovative antibody medicines by the year 2030.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 203

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 284

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 343

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 129

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
s?page=2">More News Articles